Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02850601 · ClinicalTrials.gov registry record · Phase 2
Dexamethasone Solution for the Treatment of Oral Lichen Planus
A Phase 2 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
NCT02850601 is a Phase 2 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 24 participants.
The verdict
NCT02850601, a Phase 2 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
Study Summary
The objective of this single center, 4-week, open label randomized, phase II study is to evaluate and characterize the tolerability and clinical effectiveness of dexamethasone 0.5mg/5ml solution in a mucoadhesive vehicle (Mucolox™) for the treatment of oral lichen planus.
Interventions
- DRUG Dexamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2017-02-07 |
| Est. Completion | 2019-12-20 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02850601
The ClinicalTrials.gov registry entry for NCT02850601 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexamethasone is the first listed.
NCT02850601 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02850601 about?
NCT02850601 is a clinical study titled "Dexamethasone Solution for the Treatment of Oral Lichen Planus". The objective of this single center, 4-week, open label randomized, phase II study is to evaluate and characterize the tolerability and clinical effectiveness of dexamethasone 0.5mg/5ml solution in a mucoadhesive vehicle (Mucolox™) for the treatment of oral lichen planus.
What is the current status of trial NCT02850601?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2017-02-07. Estimated completion is 2019-12-20.
What interventions are being tested in trial NCT02850601?
The interventions under investigation include: Dexamethasone (DRUG).
Who is sponsoring clinical trial NCT02850601?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.